Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Lung Cancer

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.lungcan.2013.11.025PMID 24365102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasmamembrane expression.

  2012cited by this paper
• Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.

  2012cited by this paper
• Preliminary study on combined pharmacological and laser treatment in optic pit serous maculopathy after literature review.

  2012cited by this paper
• A systemic review of PET and biology in lung cancer.

  2011cited by this paper
• Regulation of cancer cell metabolism

  2011cited by this paper
• Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.

  2010cited by this paper
• Correlation of angiogenesis with 18F‐FMT and 18F‐FDG uptake in non‐small cell lung cancer

  2009cited by this paper
• FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo

  2009cited by this paper
• Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy

  2009cited by this paper
• 18F-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non–Small Cell Lung Cancer

  2009cited by this paper
• Downregulation of 18F-FDG Uptake in PET as an Early Pharmacodynamic Effect in Treatment of Non–Small Cell Lung Cancer with the mTOR Inhibitor Everolimus

  2009cited by this paper
• Role of beta-adrenoceptors in memory consolidation: beta3-adrenoceptors act on glucose uptake and beta2-adrenoceptors on glycogenolysis.

  2008cited by this paper
• Role of β-Adrenoceptors in Memory Consolidation: β3-Adrenoceptors Act on Glucose Uptake and β2-Adrenoceptors on Glycogenolysis

  2008cited by this paper
• The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

  2007cited by this paper
• Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate.

  2007cited by this paper
• The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer

  2007cited by this paper
• Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.

  2006cited by this paper
• [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.

  2005cited by this paper
• Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer

  2005cited by this paper
• Fluorodeoxyglucose Uptake Correlates with the Growth Pattern of Small Peripheral Pulmonary Adenocarcinoma

  2005cited by this paper
• Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.

  2004cited by this paper
• Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells.

  2004cited by this paper
• Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth

  2000cited by this paper
• Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer

  2000cited by this paper
• Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

  2000cited by this paper
• Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.

  2000cited by this paper
• Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer.

  2000cited by this paper
• Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group.

  1999cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• 18F-FDG PET/CT for prediction of PD-L1 expression and tumor mutational burden in non-small cell lung cancer: biomarkers prediction models development and immunotherapy responses verification

  2025cites this paper
• Perfluoro-tert-butoxylated Monosaccharides for Metabolic 19F Magnetic Resonance Imaging in Hepatocellular Carcinoma Detection

  2025cites this paper
• Solute carrier family 2 member 3: A central mediator in aerobic glycolysis contributing to tumor malignant progression

  2025cites this paper
• Using 18F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer

  2025cites this paper
• GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma

  2024cites this paper
• Combination of circulating tumor cells and 18F‐FDG PET/CT for precision diagnosis in patients with non‐small cell lung cancer

  2024cites this paper
• Optimising hypoxia PET imaging and its applications in guiding targeted radiation therapy for non‐small cell lung cancer: a scoping review

  2024cites this paper
• SSB expression is associated with metabolic parameters of 18F-FDG PET/CT in lung adenocarcinoma and can improve diagnostic efficiency

  2024cites this paper
• Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer.

  2024cites this paper
• Association Analysis of Maximum Standardized Uptake Values Based on 18F-FDG PET/CT and EGFR Mutation Status in Lung Adenocarcinoma

  2023cites this paper
• Predictive value of 18F‐FDG PET/CT and serum tumor markers for tumor mutational burden in patients with non‐small cell lung cancer

  2023cites this paper
• Establishing mammalian GLUT kinetics and lipid composition influences in a reconstituted-liposome system

  2023cites this paper
• Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer

  2023cites this paper
• The radiomic biomarker in non-small cell lung cancer: 18F-FDG PET/CT characterisation of programmed death-ligand 1 status.

  2023cites this paper
• Programmed death ligand‐1 expression and occult lymph node metastasis in non‐small cell lung cancer

  2023cites this paper
• Value of 18F-FDG PET/CT Based on PD-L1 to Predict Outcomes of Immunotherapy in NSCLC

  2023cites this paper
• Artificial intelligence-based radiomics for the prediction of nodal metastasis in early-stage lung cancer

  2023cites this paper
• Potentials of Non-Invasive 18F-FDG PET/CT in Immunotherapy Prediction for Non–Small Cell Lung Cancer

  2022cites this paper
• [18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules

  2022cites this paper
• Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis

  2022cites this paper
• Combination of Circulating Cell-Free DNA and Positron Emission Tomography to Distinguish Non-Small Cell Lung Cancer from Tuberculosis.

  2022cites this paper
• Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer

  2022cites this paper
• Clinical value of PET/CT in identifying patients with oligometastatic /oligoprogressive disease among first-line tyrosine kinase inhibitor-treated advanced EGFR-mutant non-small cell lung cancer: Implications from survival comparisons.

  2022cites this paper
• Evaluation of Amide Proton Transfer‐Weighted Imaging for Lung Cancer Subtype and Epidermal Growth Factor Receptor: A Comparative Study With Diffusion and Metabolic Parameters

  2022cites this paper
• Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer

  2022cites this paper
• University of Groningen F-18-FDG PET/CT Scans Can Identify Sub-Groups of NSCLC Patients with High Glucose Uptake in the Majority of Their Tumor Lesions

  2021cites this paper
• Clinical Effectiveness of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with a Poor Performance Status

  2021cites this paper
• Diagnostic test accuracy of 18F-FDG PET/CT for prediction of programmed death ligand 1 (PD-L1) expression in solid tumours: a meta-analysis.

  2021cites this paper
• Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer

  2021cites this paper
• Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.

  2021cites this paper
• 18F-FDG PET/CT Scans Can Identify Sub-Groups of NSCLC Patients with High Glucose Uptake in the Majority of Their Tumor Lesions

  2021cites this paper
• FDG PET correlates weakly with HIF-1α expression in solid tumors: a meta-analysis

  2020cites this paper
• Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.

  2020cites this paper
• Mechanistic Insights into Protein Stability and Self-aggregation in GLUT1 Genetic Variants Causing GLUT1-Deficiency Syndrome

  2020cites this paper
• The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer

  2020cites this paper
• 18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer

  2020cites this paper
• Associations Between FDG PET and Expression of VEGF and Microvessel Density in Different Solid Tumors: A Meta-analysis.

  2020cites this paper
• LKB1/STK11 Expression in Lung Adenocarcinoma and Associations with Patterns of Recurrence.

  2020cites this paper
• Heterogeneity of Glucose Transport in Lung Cancer

  2020cites this paper
• Dually Enzyme- and Acid-Triggered Self-Immolative Ketal Glycoside Nanoparticles for Effective Cancer Prodrug Monotherapy.

  2020cites this paper
• Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma

  2020cites this paper
• Predictive value of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography for PD‐L1 expression in non‐small cell lung cancer: A systematic review and meta‐analysis

  2020cites this paper
• S6 ribosomal protein phosphorylation is associated with malignancy of intraductal papillary mucinous neoplasm of the pancreas

  2020cites this paper
• Impact of glucose uptake of noncancerous lung area in respiratory events for lung cancer patients.

  2020cites this paper
• Development of GLUT1-targeting alkyl glucoside-modified dihydroartemisinin liposomes for cancer therapy.

  2020cites this paper
• F-18 fluorodeoxyglucose uptake in lymph nodes and sonographic features on endobronchial ultrasonography predict lymph node metastasis in lung cancer patients

  2020cites this paper
• Diagnostic value of 68Ga-PSMA PET/CT for detection of PTEN expression in prostate cancer: A pilot study

  2020cites this paper
• Glucose metabolism in idiopathic pulmonary fibrosis

  2020influential citation
• PET standardized uptake values of primary lung cancer for comparison with tumor volume doubling times.

  2020cites this paper
• Correlation between maximum standardized uptake values on FDG-PET and microenvironmental factors in patients with clinical stage IA radiologic pure-solid lung adenocarcinoma.

  2019cites this paper
• 18F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer

  2019cites this paper
• PET is only moderately informative regarding theranostic Ttarget HIF-1α expression in solid tumors: A meta-analysis

  2019cites this paper
• Diagnostic Value of 68Ga-PSMA PET/CT for Detection of Phosphatase and Tensin Homolog Expression in Prostate Cancer: A Pilot Study

  2019cites this paper
• Prognostic value of dual-point fluorine-18 fluorodeoxyglucose PET imaging, partial volume correction and glucose transporter-1 expression in resected nonsmall cell lung cancer patients.

  2019cites this paper
• CT-histogram approach to predict lymph node metastasis in patients with c-stage IA lung cancer.

  2019cites this paper
• Cellular internalization pathways of glucose-functionalized gold nanoparticles

  2019cites this paper
• Cancer‐associated fibroblasts modify lung cancer metabolism involving ROS and TGF‐&bgr; signaling

  2019cites this paper
• Computational Tools for the Untargeted Assignment of FT-MS Metabolomics Datasets

  2019cites this paper
• Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.

  2019cites this paper
• Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer—effects of hypoxia

  2018cites this paper
• Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung.

  2018cites this paper
• Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET.

  2018cites this paper
• Uptake mechanism of metabolic-targeted gold nanoparticles.

  2018cites this paper
• Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.

  2018cites this paper
• Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells

  2018cites this paper
• Identification of key genes and long non-coding RNAs in celecoxib-treated lung squamous cell carcinoma cell line by RNA-sequencing

  2018influential citation
• Non-small cell lung carcinoma: understanding cancer microenvironment to drive immunotherapy and patients’ selection

  2018cites this paper
• Relation of EGFR Mutation Status to Metabolic Activity in Localized Lung Adenocarcinoma and Its Influence on the Use of FDG PET/CT Parameters in Prognosis.

  2018cites this paper
• The assessment of correlation and prognosis among 18F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients

  2018influential citation
• General introduction and outline

  2018cites this paper
• Standardized Uptake Values Derived from 18F-FDG PET May Predict Lung Cancer Microvessel Density and Expression of KI 67, VEGF, and HIF-1α but Not Expression of Cyclin D1, PCNA, EGFR, PD L1, and p53

  2018cites this paper
• Elevated Metabolic Activity on 18F-FDG PET/CT Is Associated with the Expression of EZH2 in Non-small Cell Lung Cancer.

  2017cites this paper
• Potential Utility of FDG PET-CT as a Non-invasive Tool for Monitoring Local Immune Responses

  2017cites this paper
• Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters.

  2017cites this paper
• Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC

  2017cites this paper
• Clinical PET imaging of tumour hypoxia in lung cancer

  2017cites this paper
• Hypoxia 18F-FAZA PET/CT imaging in lung cancer and high-grade glioma: open issues in clinical application

  2017cites this paper
• Treatment response assessment and response guided adaptive treatment

  2017cites this paper
• PET-CT, Bio-imaging for Predicting Prognosis and Response to Chemotherapy in Patients with Lung Cancer

  2017cites this paper
• Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer

  2017cites this paper
• Correlation Between Infection Status of Epstein-Barr Virus and 18F-Fluorodeoxyglucose Uptake in Patients with Advanced Gastric Cancer.

  2017cites this paper
• Metabolic characteristics of programmed cell death‐ligand 1‐expressing lung cancer on 18F‐fluorodeoxyglucose positron emission tomography/computed tomography

  2017cites this paper
• Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies

  2017cites this paper
• Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma

  2017cites this paper
• A Glimpse of Membrane Transport through Structures-Advances in the Structural Biology of the GLUT Glucose Transporters.

  2017cites this paper
• The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients.

  2016cites this paper
• Noninvasive Measurement of mTORC1 Signaling with 89Zr-Transferrin

  2016cites this paper
• University of Groningen Imaging and clinical outcome of non-small cell lung cancer

  2016cites this paper
• Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma

  2016cites this paper
• Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status

  2016cites this paper
• Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

  2016cites this paper
• Mechanistic Study of Human Glucose Transport Mediated by GLUT1

  2016cites this paper
• An exploratory study of volumetric analysis for assessing tumor response with 18F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC)

  2016cites this paper
• GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters

  2016cites this paper
• Roles of facilitative glucose transporter GLUT1 in ( 18 F)FDG positron emission tomography (PET) imaging of human diseases

  2015cites this paper
• Image-derived biomarkers and multimodal imaging strategies for lung cancer management

  2015cites this paper
• Role of Imaging Biomarkers in Predicting Anaplastic Lymphoma Kinase–Positive Lung Adenocarcinoma

  2015cites this paper
• Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[18F]Fluoro-d-Glucose Uptake in Prostate Cancer Mouse Xenografts

  2015cites this paper
• Associations between the standardized uptake value of (18)F-FDG PET/CT and demographic, clinical, pathological, radiological factors in lung cancer.

  2015cites this paper
• PET-based analysis of tumor glucose metabolism and tumor hypoxia before and during anti-neoplastic treatment

  2015cites this paper